Industry NewsMinoryx Therapeutics Announces Dosing of First Patient in ADVANCE Trial, a Phase 2/3 Clinical Study of MIN-102 in Patients with Adrenomyeloneuropathy (AMN)
Industry NewsScientists Identify Lymph-Node Positive Breast Cancer Patients Who May Develop Incurable Secondary Cancers
Industry NewsPixium Vision Receives FDA Approval to Begin Human Clinical Study of its PRIMA Retinal Implant